指南与共识产科母胎医学

孕前糖尿病孕妇治疗核心结局指标集:国际共识研究

A core outcome set for the treatment of pregnant women with pregestational diabetes: an international consensus study.
指南 / 共识 · BJOG · 2021-08-03

该国际共识研究旨在为评估孕前糖尿病孕妇治疗干预效果的随机对照试验制定核心结局指标集。研究通过系统综述提取131个独特结局,经三轮在线eDelphi调查(205名首轮参与者,第二轮174/205即85%,第三轮165/174即95%完成)及共识会议,最终确定19个核心结局。该指标集有望改善试验间比较与证据合成。

要点

  • 最终核心结局集包含19个结局,涵盖母体、胎儿及新生儿方面。
  • 系统综述从67篇符合纳入标准的文献中提取了131个独特结局。
  • 三轮eDelphi调查首轮205人参与,第二轮完成率85%(174/205),第三轮完成率95%(165/174)。

核心结论

  • 该核心结局指标集将有助于改善随机对照试验间的比较,促进稳健的证据合成,并优化孕前糖尿病孕妇治疗研究的效率。

研究设计与样本

  • 共识制定研究,包括系统综述、三轮在线eDelphi调查及共识会议。
  • 首轮有205名利益相关者完成,第二轮完成率为85%(174/205),第三轮完成率为95%(165/174)。

主要发现

  • 从67篇符合完整纳入标准的文献中提取了131个独特结局。
  • 共识会议最终选择19个结局纳入核心结局指标集。

关键数值与推荐

  • 纳入核心结局指标集的19个结局包括:孕期各三个月特异性糖化血红蛋白、孕期体重增加、严重母体低血糖、糖尿病酮症酸中毒、流产、妊娠期高血压、子痫前期、母体死亡、出生体重、大于胎龄儿、小于胎龄儿、出生时孕周、早产、分娩方式、肩难产、新生儿低血糖、先天畸形、死产和新生儿死亡。

临床怎么用

  • 未来评估孕前糖尿病孕妇治疗干预效果的随机对照试验应报告该核心结局指标集中的19个结局,以促进证据合成与比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To develop a core outcome set (COS) for randomised controlled trials (RCTs) evaluating the effectiveness of interventions for the treatment of pregnant women with pregestational diabetes mellitus (PGDM). DESIGN: A consensus developmental study. SETTING: International. POPULATION: Two hundred and five stakeholders completed the first round. METHODS: The study consisted of three components. (1) A systematic review of the literature to produce a list of outcomes reported in RCTs assessing the effectiveness of interventions for the treatment of pregnant women with PGDM. (2) A three-round, online eDelphi survey to prioritise these outcomes by international stakeholders (including healthcare professionals, researchers and women with PGDM). (3) A consensus meeting where stakeholders from each group decided on the final COS. MAIN OUTCOME MEASURES: All outcomes were extracted from the literature. RESULTS: We extracted 131 unique outcomes from 67 records meeting the full inclusion criteria. Of the 205 stakeholders who completed the first round, 174/205 (85%) and 165/174 (95%) completed rounds 2 and 3, respectively. Participants at the subsequent consensus meeting chose 19 outcomes for inclusion into the COS: trimester-specific haemoglobin A1c, maternal weight gain during pregnancy, severe maternal hypoglycaemia, diabetic ketoacidosis, miscarriage, pregnancy-induced hypertension, pre-eclampsia, maternal death, birthweight, large for gestational age, small for gestational age, gestational age at birth, preterm birth, mode of birth, shoulder dystocia, neonatal hypoglycaemia, congenital malformations, stillbirth and neonatal death. CONCLUSIONS: This COS will enable better comparison between RCTs to produce robust evidence synthesis, improve trial reporting and optimise research efficiency in studies assessing treatment of pregnant women with PGDM. TWEETABLE ABSTRACT: 165 key stakeholders have developed #Treatment #CoreOutcomes in pregnant women with #diabetes existing before pregnancy.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Kgosidialwa O, Bogdanet D, Egan AM, et al. A core outcome set for the treatment of pregnant women with pregestational diabetes: an international consensus study. BJOG. 2021. PMID: 34218508. doi:10.1111/1471-0528.16825

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。